MoneyWorks4Me

GlaxoSmithKline Pharmaceuticals to consider audited financial results

04 Feb 2013 Evaluate

GlaxoSmithKline Pharmaceuticals has informed that a meeting of the board of directors of the company will be held on February 19, 2013, to consider the approval of audited financial results for the year ended December 31, 2012 and to recommend dividend, if any, on the equity shares of the company.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1783.25
Dr. Reddys Labs. 1202.40
Cipla 1329.50
Lupin 2007.10
Zydus Lifesciences 1154.00
View more..